Stocks
Halozyme (HALO) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.52 | 3.62 | 2.57 | 1.39 | 3.49 | 1.90 | |||
| Changes by years, y/y, % | +174% | +591% | -29% | -46% | +152% | +78.8% | |||
Halozyme. Debt/EBITDA
Halozyme. Debt/EBITDA, changes, %
Halozyme (HALO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.10 | 1.22 | 0.96 | 3.53 | 2.93 | 1.90 | ||
| Changes by years, y/y, % | -48% | -36% | -34% | +151% | +167% | |||
| Changes by quarters, q/q, % | -22% | +12% | -21% | +266% | -17% | |||
